Today, our CEO and Co-Founder Dr Ángel Alberich-Bayarri participated in the Microsoft Envision AI Connection! He's been part of the “AI for Social and Environmental Innovation” roundtable, an exciting discussion about the impact of #AI on #health, #education and #climate, moderated by Jean-Philippe Courtois, alongside Anna Cejudo (Founderz) and Natalia Adler (Mitiga Solutions). Joining Microsoft at this event has been a great opportunity to explain and showcase how AI is impacting healthcare and, consequently, improving patient outcomes.
On #WorldProstateCancerDay, we want to raise awareness on one of the most common types of #cancer among men worldwide. 🔎 Early detection and accurate diagnosis are crucial for effective treatment and improved outcomes. That's why we're dedicated to providing healthcare professionals with the tools and knowledge they need to stay at the forefront of prostate cancer management. Serving that purpose, you can join us tomorrow on for an exclusive webinar endorsed by SERAM - Sociedad Española de Radiología Médica where you'll have the opportunity to learn from renowned experts, Kai Vilanova MD, PhD and Dr. Margarita García Fontes. We want to honor this occasion by empowering you with the latest advancements, that ultimately provide the best possible care for your patients. Register now on the webinar below ⬇️ https://bit.ly/3wSrNfo #Radiology #HealthcareInnovation #MedicalImaging
🥇 We can officially state that Quibim is the Best Workplace in Technology 2024! Great Place To Work Spain has announced it this afternoon in the first edition of the ranking Best Workplaces in Technology 2024 Spain, in which we have reached the first position. We have obtained a level of trust of 95%, which reflects the high degree of satisfaction and commitment of our team, and this award proves it! Let's keep it up! #BestWorkplacesenTecnología2024 #BestWorkplaces2024 #beaquibimer
📣 Are you ready to join an intercontinental conversation in radiology? Don't miss this upcoming webinar on #AI in #ProstateCancer- with clinical cases presented 📋 📆 Save the date: June 12, 18:30 (CEST) - Spain | 13:30 (GMT-3) - LATAM Language: Spanish We present this webinar endorsed by SERAM - Sociedad Española de Radiología Médica, and it will feature discussions of real #clinicalcases with two top radiologists from Spain and Uruguay: Kai Vilanova MD, PhD , MD, PhD and Dr. Margarita García Fontes. Don't miss this opportunity to learn first-hand from two experts in #Radiology and #MedicalImaging 🌟 Book your place now by clicking below ⬇️ https://bit.ly/3wSrNfo
💡It's rewarding to exchange ideas with fellow experts and demonstrate how our advanced imaging technologies and #AI innovations make a real difference in #cancerdiagnosis and #treatment. We've engaged in meaningful discussions with professionals equally committed to advancing #cancercare. If you're attending #ASCO2024, visit us at booth 34164 in Hall A to explore how we can work together. For a closer look at our technologies, you can book a personal demo to see how our solutions improve patient care 👉 https://bit.ly/3R6qUXd #MedicalImaging #HealthInnovation #CancerResearch #PatientCare
As the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting is already taking place, this is the perfect occasion to discuss about the convergence of art and science in #oncology care. We had the pleasure of interviewing Dr Gema Bruixola, a distinguished oncologist specialized in head and neck cancer: "We are very hopeful that #AI and radiomics will provide us with decision-making support, offering insights derived from vast data sets that help oncologists make more informed decisions". From the potential role of multidisciplinary tumor boards in decision-making processes to how imaging biomarker-based approaches can reshape the practice of oncology, her expertise highlights fundamental questions shaping the future of #cancertreatment. Read the full interview here and join the conversation! https://bit.ly/3wZgDp4 #ASCO2024
We are ready and looking forward to seeing you! With three abstracts presented and approved, our participation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting highlights Quibim’s strong commitment to further transform #healthcare through innovative #imagingsolutions. In words of our Co-founder and CEO, Dr Ángel Alberich-Bayarri, "We are acutely aware of the real-life impact our products are having, which is why we’re always striving to expand and enhance our products in line with scientific and health industry advancements and we look forward to sharing our latest findings with the ASCO attendees”. All about our presence at #ASCO2024 here ➡ https://bit.ly/44J2sB5
Explore our latest blog, “From Images to Insights: Quantitative PSMA-PET coupled with AI in prostate cancer clinical trials.” This post discusses the transformative role of PSMA (prostate-specific membrane antigen) in diagnosing and treating #ProstateCancer. Learn how we have utilized the potential of PSMA to convert biomarkers into meaningful predictions as our #AI-driven solutions offer unparalleled accuracy in evaluating treatment effectiveness and forecasting patient outcomes. Key highlights: 🔹 Increased diagnostic accuracy with PSMA-PET. 🔹 Advanced segmentation and image biomarker extraction. 🔹 AI solutions that predict metastatic risk, treatment response and more. Read the full post https://bit.ly/3R4F3nW, written by our Project Manager Sarah Vizel Genco, to discover how Quibim is setting a new standard in #clinicaltrials with PSMA-PET imaging.
With the endorsement of SERAM - Sociedad Española de Radiología Médica, we bring you our next webinar “Clinical case session: AI in #prostatecancer” the perfect chance to connect our shared enthusiasm for #radiology and the latest advances in diagnosis. Don't miss this opportunity to learn from the best in the industry with a unique presentation with real clinical cases. Speakers: Dr Kai Vilanova MD, PhD Dr Margarita Fontes 🗓️ Date: June 12 🕒 Time: 18:30 PM (CEST) / 13:30 PM (GMT-3) 📢 Language: Spanish Register now! https://bit.ly/3wSrNfo
"With [QP-Prostate], 10% more patients with hashtag#prostate carcinoma can be detected compared to conventional reading." - Dr Jerónimo Barrera, specialist in Radiodiagnosis at the Hospital Clínico San Carlos, Madrid. Read the full article to find out everything that this expert has to say about our flagship product ➡ https://bit.ly/3X1k6xY
